Biotech Values

[DewDiligence]

>>GTCB: Those ahole Europeans will not approve...IMO<<

That’s a reasonable knee-jerk reaction, given the manifold delays. However, I’m certainly not throwing in the towel.

Right now my main objective is to get some clarity on the inspection process:

Why is it taking longer than anticipated?

Which sites are the source of the delay?

Cambrex?
GTC’s own facilities?
The clinical sites in Europe?

What actions, if any, is GTC taking as a result of the delay?

Uncertainty is probably the worst element of all this.

If I can obtain any info on these questions, I will post. Others please do the same. I am leaving for the weekend in a few hours and will not be back until Monday, but I plan to check the board.